Thomas Davies is a Senior Research Scientist at AstraZeneca, specializing in synthetic medicinal chemistry in oncology. They are currently supervising a postdoctoral researcher and have expertise in reaction development and CRO management. Previously, Thomas completed a PhD in Synthesis for Biology and Medicine at the University of Oxford and conducted postdoctoral research in the Fürstner group at the Max-Planck-Institut für Kohlenforschung. Earlier in their career, they worked as a medicinal chemistry intern at Roche, contributing to CNS projects.
This person is not in the org chart
This person is not in any teams
This person is not in any offices